Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CORT
CORT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CORT News
Corcept Therapeutics Faces Class Action for Securities Fraud
12h ago
Globenewswire
Reminder for Corcept Therapeutics Class Action
1d ago
Globenewswire
Discovery of Hypercortisolism in Resistant Hypertension Patients
2d ago
Newsfilter
Hypercortisolism Found in 27.3% of Resistant Hypertension Patients
2d ago
Yahoo Finance
Corcept Therapeutics Receives FDA Approval for Lifyorli
3d ago
NASDAQ.COM
Corcept Therapeutics Receives FDA Approval for New Drug
3d ago
Fool
Corcept Therapeutics Shareholder Lawsuit Reminder
3d ago
Globenewswire
Multiple Companies Face Class Action Lawsuits
3d ago
Globenewswire
Class Action Filed Against Corcept Therapeutics for Securities Violations
3d ago
Globenewswire
Biotech Landscape Update: Regulatory Approvals and Mergers
3d ago
NASDAQ.COM
Corcept Lawsuit Reminder for Investors
4d ago
PRnewswire
Corcept Therapeutics Class Action Reminder for Investors
4d ago
Globenewswire
Lawsuit Claims Management Concealed FDA Warnings on Data Issues
4d ago
PRnewswire
Corcept's Drug Application Rejected by FDA, Class Action Filed
4d ago
Globenewswire
Corcept Therapeutics Receives FDA Approval for Lifyorli
4d ago
NASDAQ.COM
Corcept Faces Securities Class Action Lawsuit
5d ago
Globenewswire
Show More News
